儿科、青少年和年轻成年癌症幸存者的人乳头瘤病毒疫苗接种——弥补癌症预防和幸存者护理差距的契机
Human Papillomavirus Vaccination in Pediatric, Adolescent, and Young Adult Cancer Survivors-Opportunity to Address Gaps in Cancer Prevention and Survivorship.
作者信息
Kluczynski Melissa A, Rodriguez Elisa M, McGillicuddy Cailey S, Schlecht Nicolas F
机构信息
Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY 14263, USA.
出版信息
Vaccines (Basel). 2024 Jan 24;12(2):114. doi: 10.3390/vaccines12020114.
Abstract
The risks of secondary cancers associated with human papillomavirus (HPV) infection are as much as three times higher for survivors of pediatric, adolescent, and young adult cancer (PYAC) compared to the general population. Despite this, HPV vaccination rates among PYAC survivors remain low. Whereas pediatric oncology providers endorse HPV vaccination of PYAC survivors, many lack the resources or opportunities to intervene. The responsibility of HPV vaccination, therefore, falls to primary care providers and practices. This article provides an overview of the challenges with HPV vaccination that are distinct to PYAC survivors and discusses potential strategies to increase HPV vaccine coverage in this population.
摘要
与人类乳头瘤病毒（HPV）感染相关的继发性癌症风险，在儿童、青少年及年轻成人癌症（PYAC）幸存者中比普通人群高多达三倍。尽管如此，PYAC幸存者中的HPV疫苗接种率仍然很低。虽然儿科肿瘤学提供者认可对PYAC幸存者进行HPV疫苗接种，但许多人缺乏干预的资源或机会。因此，HPV疫苗接种的责任落在了初级保健提供者和医疗机构身上。本文概述了PYAC幸存者在HPV疫苗接种方面面临的独特挑战，并讨论了提高该人群HPV疫苗接种覆盖率的潜在策略。
相似文献
1
Human Papillomavirus Vaccination in Pediatric, Adolescent, and Young Adult Cancer Survivors-Opportunity to Address Gaps in Cancer Prevention and Survivorship.儿科、青少年和年轻成年癌症幸存者的人乳头瘤病毒疫苗接种——弥补癌症预防和幸存者护理差距的契机
Vaccines (Basel). 2024 Jan 24;12(2):114. doi: 10.3390/vaccines12020114.
2
Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers.我们是否错失了癌症预防的机会？为儿童期和青年期癌症幸存者接种人乳头瘤病毒疫苗。
Cancer. 2015 Oct 1;121(19):3395-402. doi: 10.1002/cncr.29515. Epub 2015 Jun 25.
3
HPV Vaccine Experiences and Preferences Among Young Adult Cancer Survivors and Caregivers of Childhood Cancer Survivors.HPV 疫苗在青年癌症幸存者和儿童癌症幸存者照护者中的体验和偏好。
J Cancer Educ. 2022 Oct;37(5):1519-1524. doi: 10.1007/s13187-021-01992-6. Epub 2021 Mar 19.
4
Prevalence and predictors of human papillomavirus (HPV) vaccination among young women surviving childhood cancer.儿童癌症幸存者中青年女性人乳头瘤病毒（HPV）疫苗接种的流行率和预测因素。
J Cancer Surviv. 2016 Jun;10(3):449-56. doi: 10.1007/s11764-015-0495-2. Epub 2015 Nov 16.
5
Provider-Level Barriers to Human Papillomavirus Vaccination in Survivors of Childhood and Young Adult Cancers.医疗机构层面阻碍儿童期和青年期癌症幸存者接种人乳头瘤病毒疫苗的因素。
J Adolesc Young Adult Oncol. 2022 Jun;11(3):284-289. doi: 10.1089/jayao.2021.0096. Epub 2021 Aug 17.
6
Suboptimal uptake of human papillomavirus (HPV) vaccine in survivors of childhood and adolescent and young adult (AYA) cancer.儿童期和青少年及年轻成人（AYA）癌症幸存者中 HPV 疫苗接种效果不佳。
J Cancer Surviv. 2019 Oct;13(5):730-738. doi: 10.1007/s11764-019-00791-9. Epub 2019 Jul 24.
7
Opportunities to Improve HPV Vaccination Among Pediatric, Adolescent, and Young Adult Cancer Survivors by Engaging both Oncology and Primary Care Teams.通过让肿瘤学团队和初级保健团队共同参与，为儿科、青少年和青年癌症幸存者提供改善 HPV 疫苗接种的机会。
Cancer Prev Res (Phila). 2023 Oct 2;16(10):545-547. doi: 10.1158/1940-6207.CAPR-23-0309.
8
Human papillomavirus vaccination uptake among childhood cancer survivors in Western New York.纽约西部儿童癌症幸存者的人乳头瘤病毒疫苗接种率。
Pediatr Blood Cancer. 2022 Nov;69(11):e29962. doi: 10.1002/pbc.29962. Epub 2022 Sep 12.
9
HPV vaccination coverage for pediatric, adolescent and young adult patients receiving care in a childhood cancer survivor program.在儿童癌症幸存者项目中接受治疗的儿科、青少年和年轻成年患者的人乳头瘤病毒疫苗接种覆盖率。
Prev Med Rep. 2022 Sep 7;29:101972. doi: 10.1016/j.pmedr.2022.101972. eCollection 2022 Oct.
10
HPV vaccination knowledge, intentions, and practices among caregivers of childhood cancer survivors.HPV 疫苗接种知识、意愿和儿童癌症幸存者照顾者的实践。
Hum Vaccin Immunother. 2019;15(7-8):1767-1775. doi: 10.1080/21645515.2019.1619407. Epub 2019 Jun 25.
引用本文的文献
1
Prophylactic HPV vaccination in HPV-related gynecologic cancers: European Society of Gynecological Oncology (ESGO) prevention committee opinion.人乳头瘤病毒（HPV）相关妇科癌症的预防性HPV疫苗接种：欧洲妇科肿瘤学会（ESGO）预防委员会意见
Int J Gynaecol Obstet. 2025 May;169(2):597-604. doi: 10.1002/ijgo.16120. Epub 2024 Dec 30.
本文引用的文献
1
Burden of HPV-Related Hospitalization in Germany from 2000 to 2021.2000 年至 2021 年德国 HPV 相关住院负担。
Viruses. 2023 Aug 31;15(9):1857. doi: 10.3390/v15091857.
2
Identifying Barriers to HPV Vaccination for Patients With Sickle Cell Disease and Childhood Cancer Survivors.识别镰状细胞病患者和儿童癌症幸存者 HPV 疫苗接种障碍。
J Pediatr Hematol Oncol. 2023 Nov 1;45(8):e940-e947. doi: 10.1097/MPH.0000000000002752. Epub 2023 Sep 8.
3
Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap?人乳头瘤病毒的流行病学与预防：性别差异依然存在吗？
Vaccines (Basel). 2023 Jun 4;11(6):1060. doi: 10.3390/vaccines11061060.
4
Pediatric hematology and oncology physician and nurse practitioner views of the HPV vaccine and barriers to administration.儿科血液学和肿瘤学医师及护士从业者对 HPV 疫苗的看法和接种障碍。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2224089. doi: 10.1080/21645515.2023.2224089.
5
Examining the Barriers and Opportunities for Human Papillomavirus Vaccine Delivery in Cancer Care Settings: A Mixed-Methods Study.在癌症护理环境中评估人乳头瘤病毒疫苗接种的障碍和机遇：一项混合方法研究。
Cancer Prev Res (Phila). 2023 Oct 2;16(10):581-589. doi: 10.1158/1940-6207.CAPR-23-0046.
6
The Burden of HPV-Related Hospitalizations: Analysis of Hospital Discharge Records from the Years 2015-2021 from a Southern Italian Region.人乳头瘤病毒（HPV）相关住院负担：对意大利南部某地区2015年至2021年医院出院记录的分析
Pathogens. 2023 May 17;12(5):725. doi: 10.3390/pathogens12050725.
7
Implementation barriers and considerations for recommending and administering the human papillomavirus (HPV) vaccination in oncology settings.在肿瘤治疗环境中推荐和接种人乳头瘤病毒（HPV）疫苗的实施障碍和考虑因素。
J Cancer Surviv. 2024 Oct;18(5):1481-1491. doi: 10.1007/s11764-023-01391-4. Epub 2023 May 6.
8
Reasons for refusal of the human papillomavirus vaccine among young cancer survivors.年轻癌症幸存者拒绝人乳头瘤病毒疫苗的原因。
Cancer. 2023 Feb 15;129(4):614-623. doi: 10.1002/cncr.34521. Epub 2022 Dec 19.
9
HPV Vaccination Initiation and Completion Among Pediatric, Adolescent, and Young Adult Cancer Survivors and a Comparison Population Sample Receiving Primary Care.HPV 疫苗接种在儿科、青少年和青年癌症幸存者及接受初级保健的对照人群样本中的启动和完成情况。
J Pediatr Hematol Oncol. 2023 Mar 1;45(2):e236-e243. doi: 10.1097/MPH.0000000000002484. Epub 2022 Oct 3.
10
Implementation of a provider-focused intervention for maximizing human papillomavirus (HPV) vaccine uptake in young cancer survivors receiving follow-up care in pediatric oncology practices: protocol for a cluster-randomized trial of the HPV PROTECT intervention.在儿科肿瘤诊所接受随访的年轻癌症幸存者中实施以提供者为中心的干预措施以最大程度提高人乳头瘤病毒 (HPV) 疫苗接种率：HPV PROTECT 干预措施的一项群组随机试验方案。
BMC Pediatr. 2022 Sep 12;22(1):541. doi: 10.1186/s12887-022-03562-1.
Zotero 插件